NCT05755399

Brief Summary

Transcranial focused ultrasound (tFUS) offers a platform for non-invasive imaging and treatment of the brain and pathology of the brain -- allowing high resolution imaging in both spatial and temporal dimensions. Compared with the gold- standard for brain imaging, magnetic resonance imaging (MRI), ultrasound offers reduced contrast while providing improved sampling in time through a significantly more cost-effective approach. In addition, while MRI is used to guide invasive treatments, only ultrasound can offer treatments through three primary mechanisms: 1) neuromodulation, 2) blood brain barrier modulation, and thermal/mechanical ablation through high intensity focused ultrasound (HIFU). All three treatment options require targeting therapy through the skull, which remains a barrier to clinical translation. This proposal is to test the feasibility of acquiring noninvasive targeting imaging intraoperatively prior to clinically indicated cranial neurosurgery. By acquiring volumetric ultrasound images while coregistered to previously obtained stereotactic magnetic resonance imaging, the study will be able to compare the ability of tFUS to identify and focus on brain pathology.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
16mo left

Started Oct 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Oct 2023Nov 2027

First Submitted

Initial submission to the registry

January 16, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 6, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

October 19, 2023

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

3.5 years

First QC Date

January 16, 2023

Last Update Submit

May 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Test feasibility

    For each participant feasibility is defined as 1 when any ultrasound slices are obtained and segmented. If tumor segmentation cannot be performed then this will be reported as 0, meaning not feasible. The result at the group level is a feasibility measure, i.e., the proportion of participants for whom the protocol was feasible.

    baseline

Secondary Outcomes (2)

  • Volume assessment

    Baseline

  • Morphology assessment

    Baseline

Study Arms (1)

Experimental group

EXPERIMENTAL

Participants scheduled for brain surgery

Device: Brain imaging using transcranial focused ultrasound (tFUS)

Interventions

All enrolled patients will be imaged using the MRI as standard of care. The patient will additionally be imaged using the tFUS system, ICC HIFU Synthesizer. Total imaging time will be limited to 15 minutes. Following image acquisition by the ultrasound, the standard of care surgery will be performed.

Experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to undergo informed consent
  • Scheduled and present for brain surgery
  • General Anesthesia planned
  • Neuronavigation used for surgery
  • Thin cut post-contrast imaging available for coregistration
  • At least 18 years of age

You may not qualify if:

  • Awake craniotomy planned
  • Unhealed wounds or infection of scalp
  • Diseases and conditions that would increase the morbidity and mortality of craniotomy and tumor resection (e.g. cardiopulmonary issues) in the opinion of the PI.
  • Pregnancy (also generally required for surgery)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55414, United States

RECRUITING

Study Officials

  • David Darrow, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Darrow, MD

CONTACT

Crina Peterson

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2023

First Posted

March 6, 2023

Study Start

October 19, 2023

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

May 19, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations